Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

4-HO-MiPT

From Wikipedia, the free encyclopedia
Psychedelic drug
"Miprocin" redirects here; not to be confused withMupirocin.

Pharmaceutical compound
4-HO-MiPT
Clinical data
Other names4-OH-MiPT; 4-Hydroxy-N-methyl-N-isopropyltryptamine; Miprocin
Routes of
administration
Oral[1]
Drug classNon-selectiveserotonin receptor agonist;Serotonin5-HT2A receptoragonist;Serotonergic psychedelic;Hallucinogen
ATC code
  • None
Legal status
Legal status
Pharmacokinetic data
Onset of action10–20 minutes[1][3]
Duration of action4–6 hours[1]
Identifiers
  • 3-{2-[methyl(propan-2-yl)amino]ethyl}-1H-indol-4-ol
CAS Number
PubChemCID
ChemSpider
UNII
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC14H20N2O
Molar mass232.327 g·mol−1
3D model (JSmol)
Melting point123 to 125 °C (253 to 257 °F)
  • CN(C(C)C)CCC2=CNC1=CC=CC(O)=C12
  • InChI=1S/C14H20N2O/c1-10(2)16(3)8-7-11-9-15-12-5-4-6-13(17)14(11)12/h4-6,9-10,15,17H,7-8H2,1-3H3 checkY
  • Key:RXKGHZCQFXXWFQ-UHFFFAOYSA-N checkY
  (verify)

4-HO-MiPT, also known as4-hydroxy-N-methyl-N-isopropyltryptamine or asmiprocin, is apsychedelic drug of thetryptamine and4-hydroxytryptamine families related topsilocin (4-HO-DMT).[1][3][4] It appears to be similar to psilocin in terms ofonset,duration, and effects.[1][3][4] The drug is takenorally.[1][3][4]

It acts as anon-selectiveserotonin receptor agonist, including of theserotonin5-HT2A receptor among others.[3][5] The drug is closely relatedstructurally toMiPT,4-HO-DiPT, andpsilocin (4-HO-DMT).[1]

4-HO-MiPT was first described in the literature byDavid Repke and colleagues in 1981.[6][7][3][8] Its effects in humans were subsequently described by Repke andAlexander Shulgin in 1985[4] and 1997.[1][3]

Use and effects

[edit]

According toAlexander Shulgin in his bookTiHKAL (Tryptamines I Have Known and Loved) and other publications, 4-HO-MiPT has a dose range of 12 to 25 mg, anonset of action of 10 to 20 minutes, a time to peak of 40 to 45 minutes, and aduration of 4 to 6 hours.[1][3][4][9] It has an estimated typical dose of 18.5 mg.[9] The drug has been described as at least twice aspotent aspsilocin (4-HO-DMT) at comparable doses, with 20 mg 4-HO-MiPT being subjectively stronger than 50 mg psilocin in one individual.[1][3] However, in another person, the effects of4-AcO-MiPT (aprodrug of 4-HO-MiPT) at a dose of 30 mg were described as considerably more modest than expected.[1]

The effects of 4-HO-MiPT have been reported to includeclosed-eye visuals, vividmental imagery, fewpsychedelic visuals, wave-form visuals, intense color alterations, multiple images of the same object with intense colored halos, illusory alteration of the size and distance of objects, heightening ofsenses, intensification and enhanced discrimination of sounds, increased sense of bodily processes such as blood flow and muscles,synesthesia of sound and sight, intense alteration in sense of time and distance, feelings of drifting in and out of the body, flight of ideas,philosophical thinking,euphoria, enhancedmusic appreciation, enhancederoticism, and facilitation oflove,insights,fantasy,introspection, anddiscovery.[1][3][4] Other effects includedintoxication,sedation,feeling drunk,relaxation, some initialanxiety, easy to difficult verbalcommunication, easydistraction andannoyance by externalstimuli such aslight,appetite loss, andinsomnia.[1][3][4] Physical effects of the drug have been reported to includetwitching, muscle sensations,motor incoordination, slightlightheadedness, mildvertigo,jaw clenching, and bodytremors.[1][4]

Interactions

[edit]
See also:Psychedelic drug § Interactions, andTrip killer § Serotonergic psychedelic antidotes

Pharmacology

[edit]

Pharmacodynamics

[edit]
4-HO-MiPT activities
TargetAffinity (Ki, nM)
5-HT1A5,870 (Ki)
2,590 (EC50Tooltip half-maximal effective concentration)
83% (EmaxTooltip maximal efficacy)
5-HT2A113 (Ki)
5.2–306a (EC50)
74a–100% (
Emax)
5-HT2B10.3 (EC50)
49% (
Emax)
5-HT2C750 (Ki)
166–261a (EC50)
76–98%a (
Emax)
SERT483 (Ki)
373–423 (IC50)
Notes: The smaller the value, the more avidly the drug interacts with the site.Footnotes:a = Stimulation ofIP1Tooltip inositol phosphate formation.Sources:[5][10][11]

4-HO-MiPT acts as anon-selectiveserotonin receptor agonist, including of theserotonin5-HT2A,5-HT2B, and5-HT2C receptors.[3][5][10][11] It shows the highestpotency andefficacy as an agonist of the 5-HT2A receptor, moderate potency as apartial agonist of the 5-HT2B receptor, and low potency with high-efficacy as a partial agonist of the 5-HT2C receptor.[5][11] Additionally, the drug has been found to act as a moderate-potencyserotonin transporter (SERT)blocker orserotonin reuptake inhibitor.[10] Its low affinity and potency at the5-HT1A receptor suggest minimal contribution to this drug's effects.[11] 4-HO-MiPT exhibits approximately 7-foldselectivity for activation of the serotonin 5-HT2A receptor over the serotonin 5-HT2C receptor, and 4-fold preference relative to SERT inhibition.[5][10][11] Affinities towardsreceptors outside of theserotonin receptor family have not yet been assessed.[5][11]

The drug induces thehead-twitch response, a behavioral proxy of psychedelic effects, in rodents.[5][9] Its potency for inducing the head-twitch response in mice is about 4- or 5-fold lower than that ofpsilocin.[5]

Chemistry

[edit]

4-HO-MiPT, also known as 4-hydroxy-N-methyl-N-isopropyltryptamine, is asyntheticderivative of thesubstituted tryptamine and4-hydroxytryptamine families.[1] It is the 4-hydroxyanalogue ofN-methyl-N-isopropyltryptamine (MiPT) and theN-isopropylhomologue of psilocin (4-HO-DMT).[1]

Properties

[edit]

4-HO-MiPT appears to be a relativelyunstable compound, discoloring quickly if not kept in an inert atmosphere and in a freezer.[1][3] The drug and itsprodruganalogue4-AcO-MiPT have been used as thefree base,hydrochloridesalt, andfumarate salt.[1][6][7]

Crystal structure

[edit]

In August 2019, Chadeayne et al. solved thecrystal structure of 4-HO-MiPT fumarate.[3][6] Its systematic name is [2-(4-hydroxy-1H-indol-3-yl)ethyl](methyl)propan-2-ylazanium 3-carboxyprop-2-enoate monohydrate.[6] The salt consists of a protonated tryptammonium cation and a 3-carboxyacrylate (hydrogen fumarate) anion in the asymmetric unit along with a water molecule of crystallization.[6]

Synthesis

[edit]

Thechemical synthesis of 4-HO-MiPT has been described.[1][8]

Analogues

[edit]

Analogues of 4-HO-MiPT includeN-methyl-N-isopropyltryptamine (MiPT),4-AcO-MiPT,4-MeO-MiPT,5-MeO-MiPT,4-HO-DiPT,psilocin (4-HO-DMT),4-HO-MET,4-HO-EiBT, and4-HO-McPT, among others.[1]

History

[edit]

4-HO-MiPT was first described in thescientific literature byDavid Repke and colleagues in 1981.[6][7][3][8] Its effects in humans were described by Repke andAlexander Shulgin and colleagues in 1985.[6][7][4] Thepharmacology of 4-HO-MiPT atserotonin receptors was described byDennis McKenna and Repke and colleagues in 1990.[6][12] The effects of 4-HO-MiPT in humans were described in greater detail by Shulgin in his 1997 bookTiHKAL (Tryptamines I Have Known and Loved).[1][3]

Society and culture

[edit]

Legal status

[edit]

Canada

[edit]

4-HO-MiPT is not acontrolled substance inCanada as of 2025.[13]

Russia

[edit]

4-HO-MiPT is in Schedule 1 inRussia as an analog of 4-hydroxytryptamine.[citation needed]

Sweden

[edit]

Sveriges riksdags health ministryStatens folkhälsoinstitut classified 4-HO-MiPT as "health hazard" under the actLagen om förbud mot vissa hälsofarliga varor (translatedAct on the Prohibition of Certain Goods Dangerous to Health) as of 1 November 2005, in regulation SFS 2005:733 listed as "4-hydroxi-N,N-metylisopropyltryptamin (4-HO-MIPT)", making it illegal to sell or possess.[14]

United Kingdom

[edit]

The substance could also be considered illegal in theUnited Kingdom under theMisuse of Drugs Act 1971.[citation needed]

United States

[edit]

4-HO-MiPT is an unscheduled drug in theUnited States. However, it is arguably ananalog of psilocin, which could lead to prosecution under theFederal Analog Act.[citation needed]

See also

[edit]

References

[edit]
  1. ^abcdefghijklmnopqrstuShulgin A,Shulgin A (September 1997).TiHKAL: The Continuation.Berkeley, California:Transform Press.ISBN 0-9630096-9-9.OCLC 38503252.http://www.erowid.org/library/books_online/tihkal/tihkal22.shtml
  2. ^Anvisa (24 July 2023)."RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese).Diário Oficial da União (published 25 July 2023).Archived from the original on 27 August 2023. Retrieved27 August 2023.
  3. ^abcdefghijklmnopBauer BE (6 January 2020)."4-HO-MiPT".Psychedelic Science Review. Retrieved9 October 2025.
  4. ^abcdefghiRepke DB, Grotjahn DB, Shulgin AT (July 1985). "Psychotomimetic N-methyl-N-isopropyltryptamines. Effects of variation of aromatic oxygen substituents".Journal of Medicinal Chemistry.28 (7):892–896.doi:10.1021/jm00145a007.PMID 4009612.
  5. ^abcdefghKlein AK, Chatha M, Laskowski LJ, Anderson EI, Brandt SD, Chapman SJ, et al. (April 2021)."Investigation of the Structure-Activity Relationships of Psilocybin Analogues".ACS Pharmacology & Translational Science.4 (2):533–542.doi:10.1021/acsptsci.0c00176.PMC 8033608.PMID 33860183.
  6. ^abcdefghChadeayne AR, Pham DN, Golen JA, Manke DR (September 2019)."The fumarate salts of theN-isopropyl-N-methyl derivatives of DMT and psilocin".Acta Crystallographica Section E.75 (Pt 9):1316–1320.Bibcode:2019AcCrE..75.1316C.doi:10.1107/S2056989019011253.PMC 6727059.PMID 31523457.The synthesis of N-methyl-N-isopropyltryptamine (MiPT) was reported in 1981 (Repke et al., 1981). In 1985, Repke and co-workers reported that of the compounds in the series of N,N-dialkyl-4-hydroxytryptamines, the N-methyl-N-isopropyl derivative (4-HO-MiPT) is the most potent based upon qualitative effects on humans (Repke et al., 1985). Later quantitative studies showed the N-methyl-N-isopropyl derivatives of DMT and psilocin to be more potent as seratonin-1A, 2A and 2B receptors compared to the analogous dimethyl compounds (McKenna et al., 1990).
  7. ^abcdChadeayne AR, Pham DN, Golen JA, Manke DR (April 2020)."Bis(4-hy-droxy-N-isopropyl-N-methyl-trypt-ammo-nium) fumarate: a new crystalline form of miprocin".Acta Crystallographica Section E.76 (Pt 4):514–517.Bibcode:2020AcCrE..76..514C.doi:10.1107/S2056989020002923.PMC 7133045.PMID 32280495.4-Hydroxy-N-methyl-N-isopropyltryptamine (4-HOMiPT), aka 'miprocin', is a psilocybin analogue. Its synthesis was first reported in 1981 by Repke and co-workers (Repke et al., 1981); its psychedelic effects were later described in collaboration with Alexander Shulgin (Repke et al., 1985). Miprocin is reported to produce an experience that is both relaxing, stoning and mildly sedating with a marked physical stimulation that distinguishes it from related substances such as psilocybin mushrooms. In a report last year, we presented the first structure of 4-HO-MiPT (Chadeayne, Pham et al., 2019a), which crystallizes as the hydrofumarate monohydrate. Herein we report the reaction of this salt with lead(II) acetate to generate the 4-hydroxy-N-isopropyl-N-methyltryptaminium/fumarate compound in a 2:1 ratio. The solid state structure of the new salt is presented here.
  8. ^abcRepke DB, Ferguson WJ, Bates DK (1981). "Psilocin analogs II. Synthesis of 3-[2-(dialkylamino)ethyl]-, 3-[2-(N-methyl-N-alkylamino)ethyl]-, and 3-[2-(cycloalkylamino)ethyl]indol-4-ols".Journal of Heterocyclic Chemistry.18 (1):175–179.doi:10.1002/jhet.5570180131.ISSN 0022-152X.
  9. ^abcHalberstadt AL, Chatha M, Klein AK, Wallach J, Brandt SD (May 2020)."Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species".Neuropharmacology.167 107933.doi:10.1016/j.neuropharm.2019.107933.PMC 9191653.PMID 31917152.Table 4 Human potency data for selected hallucinogens. [...]
  10. ^abcdKozell LB, Eshleman AJ, Swanson TL, Bloom SH, Wolfrum KM, Schmachtenberg JL, et al. (April 2023)."Pharmacologic Activity of Substituted Tryptamines at 5-Hydroxytryptamine (5-HT)2A Receptor (5-HT2AR), 5-HT2CR, 5-HT1AR, and Serotonin Transporter".The Journal of Pharmacology and Experimental Therapeutics.385 (1):62–75.doi:10.1124/jpet.122.001454.PMC 10029822.PMID 36669875.
  11. ^abcdefGlatfelter G, Walther D, Partilla J, Chadeayne AR, Manke DR, Baumann MH (1 June 2024)."Pharmacological profiles and psychedelic-like effects of 4-hydroxy-, 4-acetoxy-, and 4-methoxy-N- methyl- N- isopropyltryptamine".The Journal of Pharmacology and Experimental Therapeutics.389: 281.doi:10.1124/jpet.281.923160.ISSN 0022-3565.
  12. ^McKenna DJ, Repke DB, Lo L, Peroutka SJ (March 1990). "Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes".Neuropharmacology.29 (3):193–198.doi:10.1016/0028-3908(90)90001-8.PMID 2139186.
  13. ^"Controlled Drugs and Substances Act".Department of Justice Canada. Retrieved19 January 2026.
  14. ^"Förordning om ändring i förordningen (1999:58) om förbud mot vissa hälsofarliga varor" [Regulation amending the Ordinance (1999: 58) on Prohibition against certain dangerous goods](PDF).Swedish Code of Statutes (in Swedish). 6 October 2005. Archived fromthe original(PDF) on 26 June 2021. Retrieved6 September 2013.

External links

[edit]
Tryptamines
No ring subs.
4-Hydroxytryptamines
5-Hydroxytryptamines
5-Methoxytryptamines
Other ring subs.
α-Alkyltryptamines
Others
Cyclized
Bioisosteres
Phenethylamines
Scalines
2C-x
3C-x
DOx
4C-x
Ψ-PEA
MDxx
FLY
25x-NB (NBOMes)
Others
Cyclized
Lysergamides
Others
Natural sources
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
DATTooltip Dopamine transporter
(DRIsTooltip Dopamine reuptake inhibitors)
NETTooltip Norepinephrine transporter
(NRIsTooltip Norepinephrine reuptake inhibitors)
SERTTooltip Serotonin transporter
(SRIsTooltip Serotonin reuptake inhibitors)
VMATsTooltip Vesicular monoamine transporters
Others
Tryptamines
4-Hydroxytryptamines
andesters/ethers
5-Hydroxy- and
5-methoxytryptamines
N-Acetyltryptamines
α-Alkyltryptamines
α-Ketotryptamines
Cyclized tryptamines
Isotryptamines
Related compounds
Retrieved from "https://en.wikipedia.org/w/index.php?title=4-HO-MiPT&oldid=1338063309"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp